Hyperostosis in Combination With Low Skull Density Ratio: A Potential Contraindication for Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy.
Authors: Yuen J, Miller KJ, Klassen BT, Lehman VT, Lee KH, Kaufmann TJ
Since its approval in treating a number of movement disorders, magnetic resonance imaging-guided focused ultrasound (MRgFUS) has been adopted rapidly as one of the standard treatment modalities internationally. However, the efficiency of the energy delivered by the ultrasonic waves is largely determined by the highly variable bone morphology and density characteristics of the skull. One of the widely accepted indices used to facilitate patient selection is the skull density ratio (SDR). Earlier literature suggested that an SDR of less than 0.4 would be unfavorable for MRgFUS treatment. Some prior studies have excluded patients with hyperostosis. However, there is little published data regarding the impact of other skull features such as hyperostosis on treatment success. We present the case of a 66-year-old man with medically refractory essential tremor who had an SDR of 0.38 and extensive hyperostosis frontalis interna and underwent attempted MRgFUS thalamotomy treatment. However, intraoperatively the treatment was unsuccessful in generating sufficiently elevated temperature to create a lesion of the usual desired volume, and as expected, there was minimal clinical improvement. For comparison, we also summarize a case series of 4 other patients with an SDR of less than 0.4 who had successful outcomes. We believe that SDR should not be used as the only means of selecting patients for MRgFUS. Instead, important factors such as hyperostosis should be taken into consideration for patient selection and pretreatment counseling.
Introduction
Purpose
Thermal Ablation
Study Objective
To assess whether skull density ratio (SDR) alone should determine candidacy for MRgFUS by examining the impact of low SDR and hyperostosis on treatment success through a failed case and comparison cases.
Animal model / Human subject
Human (Homo sapiens), strain: N/A, 66 years, male
Disease model
Essential tremor
MRI or image guidance method
Magnetic resonance imaging–guided (MRgFUS)
Targeted brain region(s)
Thalamus
Target coordinates
AP
Cargo name and characteristics
Not Provided
Route of administration
not specified
Outcomes and Safety
Summary of Outcomes
MRgFUS failed to reach ablative temperatures and produced minimal clinical improvement in a patient with SDR 0.38 and marked hyperostosis frontalis interna, whereas four other patients with SDR <0.4 but no hyperostosis achieved satisfactory lesioning and nearly complete tremor improvement when intraoperative peak temperatures reached ~55–61°C (total energy 36.9–134.7 kJ, peak per sonication 13.6–27.5 kJ across 5–14 sonications).
Duration of biological effect
6 mo
Safety-related matter
One patient experienced transient headache and dizziness during the MRgFUS procedure and another died 2 months after treatment (death considered unrelated). The report also documents procedural failure to generate therapeutic lesions (minimal clinical improvement) and raises safety/efficacy concerns that hyperostosis may cause undesirable thermal spread and unequal power deposition (sidelobes).
Brain Region
Ultrasound Parameters
Ultrasound instrument
Exablate Neuro, software version 7.33; Insightec
FUS Frequency
Not reported in provided text
FUS Intensity
750 W
FUS Pressure
Not reported
FUS Mode
pulsed
Pulse duration
Not provided
Duration of a single FUS session
Not provided
Focal Characteristics
Not provided
Treatment frequency
Single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search